Top in ID: Marrazzo replaces Fauci as head of NIAID; RSV vaccines become accessible
Click Here to Manage Email Alerts
Healio | Infectious Disease News Editorial Board Member Jeanne M. Marrazzo, MD, MPH, was appointed director of the National Institute of Allergy and Infectious Diseases, replacing Anthony S. Fauci, MD, who stepped down in December.
Marrazzo is expected to begin her work in the fall, facilitating research in more than 100 countries and managing a $6.3 billion budget and a staff of 5,300. She is equipped with “a wealth of leadership experience from leading clinical trials and translational research,” NIH Acting Director Lawrence A. Tabak, DDS, PhD, said in a statement. It was the top story in infectious disease last week.
Another top story was about the CDC’s recommendation that respiratory syncytial virus (RSV) vaccination be based on shared clinical decision-making between patients and their physicians. Experts weighed in on the meaning of the recommendation and its implications for older patients in the United States.
Read these and more top stories in infectious disease below:
NIH picks Marrazzo to replace Fauci as head of NIAID
Marrazzo will be the next director of the National Institute of Allergy and Infectious Diseases, the NIH announced. Read more.
Older adults first in line for RSV vaccines, but will they roll up their sleeves?
This coming fall and winter, older adults in the United States will face a decision: Should they roll up their sleeves to receive the world’s first approved vaccines against RSV? Read more.
Survey shows only 68% of people with hepatitis C aware of the infection
A nationally representative survey revealed that of the more than 2 million people with current hepatitis C virus infection, only 68% are aware of their infection. Read more.
Should patients bundle COVID-19, flu and RSV vaccines into single visit?
This fall, older adults in the United States will have the opportunity to receive three vaccines to against fall and winter season respiratory illnesses — COVID-19, influenza and RSV. Read more.
Leprosy cases in Florida suggest infection is endemic in Southeast US
Nearly one in five U.S. cases of leprosy is reported in Florida, with roughly 81% of cases in the state reported in central Florida, according to a study. Read more.